Financial statements Polpharm
Balance sheet data of POLPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 433 887,36 | 1 392 116,13 | 1 414 950,72 | 1 337 030,11 | 1 444 396,70 | 1 636 519,92 |
| A. Fixed assets | 740 862,21 | 654 628,91 | 714 822,76 | 570 066,26 | 493 489,42 | 471 421,07 |
| B. Current assets | 693 025,15 | 737 487,22 | 700 127,96 | 766 963,85 | 950 907,28 | 1 165 098,85 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 433 887,36 | 1 392 116,13 | 1 414 950,72 | 1 337 030,11 | 1 444 396,70 | 1 636 519,92 |
| A. Equity | 749 185,05 | 752 698,35 | 755 866,30 | 606 337,18 | 760 139,00 | 779 347,54 |
| B. Liabilities and provisions for liabilities | 684 702,31 | 639 417,78 | 659 084,42 | 730 692,93 | 684 257,70 | 857 172,38 |
| I. Long-term liabilities | - | 0,00 | - | 0,00 | 0,00 | 2 350,00 |
| II. Short-term liabilities | 684 651,31 | 639 417,78 | - | 730 692,93 | 684 257,70 | 854 822,38 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.